Pfizer Receives Positive CHMP Opinion for Oncology Biosimilar, RUXIENCE™ (rituximab)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/3/2026

1. SNOW
2. AVGO
3. RARE
4. HPE
5. FIVE
6. SPY
7. VRTS
8. NTAP
9. OLLI
10. NTSK

Go back to Pfizer Receives Positive CHMP Opinion for Oncology Biosimilar, RUXIENCE™ (rituximab)
Pfizer Inc. (NYSE: PFE) Delayed: 28.69 -0.33 (1.14%)
Previous Close $29.02    52 Week High $37.39 
Open $29.09    52 Week Low $28.25 
Day High $29.21    P/E 17.39 
Day Low $28.44    EPS $1.65 
Volume 10,761,905